PEGDMA Hydrogel Biosensor for Thermal Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Wild-type glucose-galactose binding proteins (GGBPs) are not ideal for biosensors due to instability at physiological temperatures, leading to denaturation during high-temperature sterilization and potential immune responses, and existing hydrogel materials for biosensors suffer from poor mechanical stability and bioreactivity issues.
Innovation Solution
A hydrogel matrix comprising poly(ethylene glycol) dimethyacrylate (PEGDMA) with 2-hydroxy-2-methyl propiophenone (HMPP) and either methacrylic acid (MAA) or methyl methacrylate (MMA), where the PEGDMA:acrylate ratio ranges from 10:90 to 90:10 mol%, is used to covalently attach proteins, providing enhanced stability and biocompatibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If wild-type GGBPs are used in biosensors, then the biosensor can measure glucose concentrations, but the protein denatures during high-temperature sterilization and loses functionality
Solution Approach 1:
The patent applies parameter changes by modifying the protein structure through site-directed mutagenesis, specifically replacing amino acid residues (e.g., Phe131, Phe133, Trp183) to enhance thermal stability. This allows the GGBP to withstand high-temperature sterilization (121°C) while maintaining glucose binding functionality, directly resolving the contradiction between biosensor functionality and protein stability.
Solution Approach 2:
The patent creates a composite system by immobilizing the engineered GGBP within a hydrogel matrix (such as polyacrylamide or agarose). This composite structure provides both the biological recognition function (glucose binding) and physical stability (thermal and mechanical resistance), allowing the biosensor to maintain functionality through sterilization and during operation.
2Ease of manufacture
If high-temperature sterilization is applied to the biosensor, then sterilization is achieved, but the GGBP denatures and becomes useless
Solution Approach 1:
The patent modifies the protein's thermal stability parameters through amino acid substitutions that increase the melting temperature (Tm) of the GGBP. This allows the biosensor to undergo standard autoclaving sterilization (121°C for 15-20 minutes) without protein denaturation, enabling conventional manufacturing and sterilization protocols to be used.
Solution Approach 2:
The patent performs preliminary protein engineering (site-directed mutagenesis) before biosensor assembly and sterilization. By pre-engineering the thermally stable GGBP variant, the biosensor can subsequently withstand high-temperature sterilization without loss of function, ensuring both manufacturability and reliability.
3Reliability
If natural hydrogels like alginate or PHEMA are used for protein immobilization, then reversible glucose binding is achieved, but mechanical stability is poor and bioreactivity is increased
Solution Approach 1:
The patent employs composite hydrogel systems that combine the advantages of different materials. For example, it uses crosslinked polyacrylamide networks or PEG-based hydrogels with controlled crosslinking densities, which provide both mechanical strength and the necessary porosity for glucose diffusion. These engineered hydrogels maintain reversible glucose binding while significantly improving mechanical stability compared to natural hydrogels.
Solution Approach 2:
The patent designs hydrogel matrices with controlled pore sizes and structures that allow glucose molecules to diffuse freely for reversible binding while providing a rigid framework for mechanical stability. The porous structure is engineered to exclude larger biomolecules (preventing biofouling) while permitting glucose transport, thus maintaining binding reversibility without sacrificing mechanical strength.
4Reliability
If binding proteins are immobilized in hydrogel matrices, then analyte-induced conformational change is allowed, but control over polymerization rate and swelling is poor
Solution Approach 1:
The patent precisely controls polymerization parameters including monomer concentration, crosslinker ratio, initiator type and amount, and polymerization temperature and time. By optimizing these parameters, the patent achieves controlled polymerization rates and consistent hydrogel swelling properties, ensuring reproducible manufacturing while maintaining the binding protein's ability to undergo analyte-induced conformational changes.
Solution Approach 2:
The patent creates local variations in hydrogel properties by using gradient crosslinking or spatially controlled polymerization. This allows different regions of the hydrogel to have optimized properties: regions with higher crosslinking density provide mechanical stability and controlled swelling, while regions with lower density allow free protein conformational changes in response to analyte binding.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution results in a biosensor with improved in vivo stability, reduced bioreactivity, and enhanced mechanical strength, allowing for continuous glucose monitoring for extended periods without significant signal loss or immune response.
Implementation Method 1
US 2005/0239155 discloses the covalent attachment of a binding molecule to a hydrogel matrix via photo-polymerization using photoinitiators such as 2-hydroxy-2-methyl propiophenone (HMPP)
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to compositions comprising a hydrogel matrix, where the matrix comprises poly(ethylene glycol) dimethyacrylate (PEGDMA), an acrylate, such as methacrylic acid (MAA) and methyl methacrylate (MMA), as well as 2-hydroxy-2 methyl propiophenone (HMPP).